US AAIPharma expands to Hungary
AAIPharma has expanded for the second time in a week, this time opening an office inn Budapest, Hungary.
The newest office in addition to an operation just launched in South Africa gives AAIPharma Inc. a contract research organization and drug development firm, a presence in 14 countries. The Budapest operation, which has seven people, augments AAIPharma’s presence in Europe. The company also has offices in Russia and Croatia. “Central and Eastern Europe is one of most dynamic regions to run clinical trials” said Ludo Reynders. AAIPharma’s CEO. “Hungary with its population of 10 million, good hospital infrastructure and the availability of patients is recognized as a key country in this region. As the needs of our biotechnology and pharmaceutical customers to run global clinical trials are ever increasing, it is important that we continue to expand our international presence in key regions such as this to meet these demands.”
Wilmington-based (North Carolina) AAIPharma Inc. is a science-based specialty pharmaceutical company with more than 22 years of drug development experience. (wral.com)
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.